2014•Gastrointestinal EndoscopyRequires access

Sa1667 The Influential Role of Levofloxacin-Susceptibility in the Success of Second Line Helicobacter pylori Eradication Using 10-day and 14-Day Levofloxacin-Containing Triple Therapy

Wei‐Chen Tai, Seng‐Kee Chuah, Keng‐Liang Wu, Ping‐I Hsu, Deng‐Chyang Wu, Yi‐Chun Chiu

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Levofloxacin, Medicine, Helicobacter pylori, Internal medicine, Helicobacter, Gastroenterology, Antibiotics, Microbiology

Back to paper search Browse research topics Original source

Sa1667 The Influential Role of Levofloxacin-Susceptibility in the Success of Second Line Helicobacter pylori Eradication Using 10-day and 14-Day Levofloxacin-Containing Triple Therapy — Research Paper | ScholarLens